论文信息 - Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience. - 字舞流文

Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience.

M. Stöckle | U. Nestle | C. Kirsch | A. Grgic | J. Lehmann | U. Zwergel | J. Kamradt | J. Pinkert | H. Suttmann | E. Gouverneur